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Background: Sleep is a highly conserved behavior, yet its duration and pattern vary extensively among species and
between individuals within species. The genetic basis of natural variation in sleep remains unknown.
Results: We used the Drosophila Genetic Reference Panel (DGRP) to perform a genome-wide association (GWA)
study of sleep in D. melanogaster. We identified candidate single nucleotide polymorphisms (SNPs) associated with
differences in the mean as well as the environmental sensitivity of sleep traits; these SNPs typically had sex-specific
or sex-biased effects, and were generally located in non-coding regions. The majority of SNPs (80.3%) affecting
sleep were at low frequency and had moderately large effects. Additive models incorporating multiple SNPs
explained as much as 55% of the genetic variance for sleep in males and females. Many of these loci are known to
interact physically and/or genetically, enabling us to place them in candidate genetic networks. We confirmed the
role of seven novel loci on sleep using insertional mutagenesis and RNA interference.
Conclusions: We identified many SNPs in novel loci that are potentially associated with natural variation in sleep,
as well as SNPs within genes previously known to affect Drosophila sleep. Several of the candidate genes have
human homologues that were identified in studies of human sleep, suggesting that genes affecting variation in
sleep are conserved across species. Our discovery of genetic variants that influence environmental sensitivity to
sleep may have a wider application to all GWA studies, because individuals with highly plastic genotypes will not
have consistent phenotypes.
Keywords: Sleep, Drosophila melanogaster, Genome-wide association, Genetic variance of environmental variationBackground
The need to sleep is near universal among animal species,
including humans [1], yet the function of sleep remains
puzzling. Sleep disorders have a devastating impact on hu-
man health. For example, individuals with narcolepsy can
experience loss of muscle control and intense hallucina-
tions during waking, which directly interferes with con-
scious activity [2]. Restless Leg Syndrome is a sensation of
discomfort in the lower limbs during the evening that re-
sults in an inability to sleep [2]. Similarly, obstructive sleep
apnea is a closing of the upper airway during sleep,
restricting the brain’s access to oxygen [2]. Individuals with
these sleep disorders suffer from increased daytime* Correspondence: susan.harbison@nih.gov
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reproduction in any medium, provided the orsleepiness and decreased cognitive performance [2,3]. Poor
sleep habits as well as disordered sleep are risk factors for
other diseases, such as obesity, high blood pressure, cardio-
vascular disease, and depression [2,4]. Sleep patterns and
duration vary both among species and within species [5],
due in part to segregating genetic variation [6-10], implying
that sleep and risk factors for sleep disorders are at least
partly under genetic control. However, the genes main-
taining genetic variation in sleep are not known.
Sleep characteristics in mammals have been observed
in Drosophila melanogaster, which facilitates the use of
this powerful genetic model organism to study sleep
[11,12]. Drosophila has several key advantages over mam-
mals. One advantage is the extensive collections of stocks
with mapped mutations, chromosomal deletions, and trans-
genic modifications that can be directly tested for their im-
pact on sleep. A second key advantage is the ability to
phenotype flies with identical genotypes under controlled
environmental conditions, enabling the detection of en-al Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and










































































Figure 1 Partitioning of variance in sleep in the DGRP lines.
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http://www.biomedcentral.com/1471-2164/14/281vironmental sensitivity and genotype-by-environment inter-
actions. Several studies have already capitalized on commu-
nity resources, together screening more than 15,000
mutations for their effects on sleep [13-15]. A small num-
ber of mutations (e.g., in Shaker, fumin, and sleepless) have
major effects on sleep [13-16], but many mutations have
more subtle quantitative effects [17]. A complementary
approach to mutagenesis is to identify loci at which alleles
with more subtle effects segregate in natural populations
[18,19]. Single nucleotide polymorphisms (SNPs), inser-
tions, and deletions in a natural population of flies are mu-
tations that have survived the filter of natural selection and
can be tested via genome-wide association (GWA) for ef-
fects on genetic variation in sleep [20]. Here, we use a new
community resource, the Drosophila Genetic Reference
Panel (DGRP) [20], to identify SNPs associated with natural
variation in sleep. The DGRP is a panel of inbred lines that
were created by mating full siblings of wild-caught iso-
female lines for 20 generations [20]. The availability of full
sequence data, the rapid decay in linkage disequilibrium
(LD) with physical distance, and the lack of population
structure in the DGRP [20] are advantageous conditions for
a GWA study of sleep.
Using continuous sleep and activity data recordings from
groups of individuals with identical genotypes, we calcu-
lated sleep duration, the number of sleep bouts or ‘naps’,
and average sleep bout length during the day and night.
We also measured waking activity, a measure that describes
the activity level relative to the time spent awake. All
parameters of sleep architecture, as well as waking activi-
ty, were genetically variable among the DGRP lines. In
addition, we observed considerable variability in sleep a-
mong flies with identical genotypes, and the environmental
sensitivity with respect to sleep parameters was also
genetically variable. We performed GWA analyses for the
mean and environmental sensitivity of each sleep trait in
the DGRP, and found many SNPs individually associated
with each sleep trait, often with sex-specific effects. Most
(80.3%) SNPs associated with the mean and environmental
variance of sleep had relatively low minor allele frequencies
(0.024 - 0.05). Additive multi-SNP models revealed that
1–4 SNPs could explain 19.5-55.5% of the genetic variance
in sleep for females, and 18.0-55.6% of the genetic variance
in sleep for males. While further work is required to iden-
tify causal variants, we found that individual SNPs associ-
ated with sleep traits were located in genes known to have
effects on sleep in flies, in genes over-represented in the
Epidermal growth factor receptor (Egfr) pathway, and in
genes with homologs previously implicated in human sleep.
Low-frequency alleles were associated with increased envir-
onmental sensitivity. Further, genes associated with sleep
had signatures of purifying selection [20]. These observa-
tions raise the intriguing possibility that sleep may be cana-
lized in heterogeneous natural populations [21].Results
Quantitative genetic analyses
We measured day and night sleep duration, average bout
length, bout number and waking activity, separately for
males and females, in 168 DGRP lines. Quantitative genetic
analyses of each trait revealed substantial and highly sig-
nificant genetic variation among the lines for the mean of
each trait (Figure 1, Additional file 1). Estimates of broad
sense heritability (H2) for night sleep, day sleep, night bout
number, day bout number, night average bout length, day
average bout length, and waking activity, were, respectively
H2 = 0.54, H2 = 0.49, H2 = 0.42, H2 = 0.33, H2 = 0.38, H2 =
0.19 and H2 = 0.39 (Additional file 1). All sleep traits except
for night average bout length and night sleep duration were
highly sexually dimorphic (Figure 2, Additional files 1
and 2). However, for all traits there was substantial genetic
variation in sexual dimorphism (i.e., the difference in sleep
traits between males and females varied among the lines),
as shown by differences in genetic variance between fe-
males and males for most traits; significant sex by line
interaction terms; and cross-sex genetic correlations (rMF)
ranging from a low of rMF = 0.58 for day bout number to a
high of rMF= 0.84 for waking activity (Figure 2, Additional
files 1 and 2). Thus we expect that some polymorphisms
will affect sleep in both sexes, while others will have sex-
specific or sex-biased effects. The range of variation in
sleep traits encompassed by the DGRP lines is astonishing
(Figure 2, Additional file 2), with mean sleep duration
spanning much of the possible 24-hour spectrum. Night
sleep times ranged from 122 to 689 minutes in females and
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Figure 2 (See legend on next page.)
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Figure 2 Histograms of mean and the coefficient of environmental variation (CVE) for sleep duration. Blue bars denote male line means,
pink bars denote female line means, and the difference in line means between males and females (male – female) is shown by purple bars.
(a) Night sleep. (b) Male - female night sleep. (c) Day sleep. (d) Male – female day sleep. (e) Night sleep CVE. (f) Male – female night sleep CVE.
(g) Day sleep CVE. (h) Male – female day sleep CVE.
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http://www.biomedcentral.com/1471-2164/14/281tended to sleep slightly longer during the night than males
(Figure 2b). Day sleep duration ranged from 94 to 640 mi-
nutes in females and from 120 to 682 minutes in males
(Figure 2c). As previously noted in other natural popula-
tions of flies [7,22] males generally slept more during the
day than females (Figure 2d).
Sleep was highly variable among individual flies with
identical genotypes (Figure 3a), and most variable in lines
having the shortest mean sleep times. We calculated the
environmental coefficient of variation (CVE) for all sleep
parameters to determine whether there was genetic vari-
ation in the magnitude of environmental sensitivity; i.e.,
whether some lines are relatively more canalized and
others more phenotypically plastic in response to the same
random environmental effects [23]. Here, the CVE for sleep
between individuals can be estimated directly for replicates
of each line as flies from a given line in the DGRP have
identical genotypes (see Methods). We partitioned the vari-
ance in CVE between and within lines (Additional file 1).
We found that CVE had a significant genetic component
for all sleep traits, with H2 = 0.72 for night sleep duration
CVE, H
2 = 0.55 for day sleep duration CVE, H
2 = 0.31 for
night bout number CVE, H
2 = 0.47 for day bout num-
ber CVE, H
2 = 0.15 for night average bout length CVE,
H2 = 0.06 for day average bout length CVE, and H
2 = 0.24
for waking activity CVE (Additional file 1). All traits but
waking activity exhibited sexual dimorphism for CVE,
with generally greater sensitivity to environmental variation
in females than males (Figures 2e-2h; Additional files 1
and 2). There was genetic variation in the magnitude of
CVE between males and females for night sleep, day sleep,
night bout number, and day bout number, with cross-sex
genetic correlation estimates of rMF = 0.74, rMF= 0.61,
rMF= 0.71 and rMF = 0.38, respectively (Additional file 1).
Thus, we expect to be able to identify genetic variants af-
fecting environmental sensitivity for sleep traits, and some
of these variants will be the same for males and females,
while others will be sex-specific or sex-biased.
We computed genetic correlations between lines for the
mean value and CVE of each sleep trait to assess the extent
to which the same variants affect both the mean and envir-
onmental sensitivity. There were strong negative genetic
correlations (rG) between night and day sleep duration and
CVE (rG = −0.83 for night sleep duration and rG = −0.78 for
day sleep duration) (Figures 3b and 3c). For these traits, we
expect largely the same variants to affect the mean and en-
vironmental sensitivity. This pattern held for most, but notall, sleep traits. The correlations were rG = −0.75 for night
bout number, rG = −0.51 for day bout number, rG = −0.08
for night average bout length, rG = 0.86 for day average
bout length, and rG = 0.33 for waking activity (Additional
file 1). The low rG for night average bout length implies that
variants affecting the mean do not affect environmental
sensitivity, and vice versa; however, the lower genetic corre-
lations are also in part due to lower heritabilities of both
mean and sensitivity. Mean phenotypic values of all sleep
parameters in the DGRP lines are given in Additional file 3.
Genotype-phenotype associations
The DGRP lines have been sequenced [20]. We used
2,490,165 SNPs for which the minor allele is present in at
least four lines to conduct GWA analyses for the mean
and CVE of all sleep traits. With this number of SNPs there
is a distinct possibility of many false positives; we therefore
limited our significance threshold to a false discovery rate
(FDR) of 0.01 or lower for each sleep trait. We found many
SNPs associated with the mean and coefficient of environ-
mental variation of most sleep traits using this threshold
(Table 1). The exceptions were day sleep and night bout
number, for which none of the associations met this
threshold. As has been observed in human studies [24],
many SNPs were located in intergenic regions (49.1%) and
in introns (35.3%), while fewer SNPs were found in coding
sequences (15.5%), roughly corresponding to the amount
of DNA in the genome for these three categories
(Additional file 4) [25]. Consistent with the high genetic
correlation between the mean and environmental variance
for sleep duration, 95.6% of the SNPs overlapped between
night sleep mean and CVE (Table 1). As expected from the
quantitative genetic analyses of sleep phenotypes, the SNPs
significantly associated with sleep were often sex-specific
or sex-biased. We classified SNPs as sex-specific (signifi-
cant in one sex only), sex-biased (significant for both sexes,
but with greater effects in one sex versus the other), or
sex-antagonistic (significant for both sexes, but with the ef-
fects on sleep occurring in opposite directions) [26]. The
overwhelming majority of SNPs exhibited some degree of
sex dimorphism: 27.7% percent of the SNPs were sex-
specific, 51.3% were sex-biased, and 1.8% were sex-
antagonistic, with the remaining 19.2% affecting both sexes
equally (Figures 4 and 5). Quantile-quantile (Q-Q) plots
for each sleep trait show P-values deviating from the
expected distribution for some of the sleep traits. We
therefore investigated whether sleep was influenced by
Decreasing sleep
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Figure 3 (See legend on next page.)
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Figure 3 Genotypic influences on individual variability in sleep duration. (a) Night and day sleep duration for every fly in the experiment,
segregated by genotype and ordered from shortest-sleeping to longest-sleeping line. Male flies are represented by blue dots; females are
represented by pink dots. Gray horizontal bars show the range of sleep duration in each line. (b) and (c) Plot of sleep duration line mean versus
sleep duration CVE. (b) Night sleep. (c) Day sleep.
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http://www.biomedcentral.com/1471-2164/14/281population structure due to cryptic relatedness in the
DGRP. Correcting the association tests for relatedness
resulted in no appreciable differences in the Q-Q plots
(Additional files 5 and 6) or distributions of P-values
(Additional files 7 and 8), suggesting that the deviations are
not caused by population admixture. Although on average
LD decays rapidly with physical distance in the DGRP [20],
there is great variation around this average decay, such that
there are some regions of local LD, including LD associated
with polymorphic inversions. We speculated that this local
LD could cause the appearance of structure in the Q-Q
plots. We therefore assessed whether the presence or ab-
sence of common inversions in the DGRP (M. A. Carbone,
A. Yamamoto, Y. Inoue, and T. F. C. Mackay, personal
communication) were associated with sleep traits. Indeed,
day average bout length, day average bout length CVE, and
waking activity CVE were significantly associated with the
ln_3R_Mo (Missouri) inversion; day average bout length,
day bout number, and day average bout length CVE were
associated with the ln_2R_NS (Nova Scotia) inversion; and
day sleep, day sleep CVE, night bout CVE, and day bout
CVE were associated with the ln_2L_t inversion. We also
observed many instances of local LD independent of the
inversions. For night sleep, the largest regions of LD were
a ~10,277 kb region of LD from the intronic region of
CG11085 to the intronic region of fog, and a smaller 702
bp region just forward of and within CG14431 on the X
chromosome; a ~6,380 kb region of LD between an
intergenic region forward of CG12523 and within the in-
tronic region of Rbp6 on Chromosome 3L; and LD be-
tween almost exclusively male-specific SNPs in a ~345 kb
region spanning the intergenic region between α Catenin








Night sleep 160 (120) 87.5 1,552 (1,175)
Day sleep 0 (0) 0 71 (51)
Night bout no. 0 (0) 0 3 (3)
Day bout no. 3 (3) 0 340 (198)
Night average
bout length
16 (16) 68.8 1 (1)
Day average bout length 2,082 (1,174) 76.7 5 (3)
Waking activity 264 (214) 89.4 4,083 (2,727)
*Numbers of SNPs listed have FDR ≤ 0.01; numbers of SNPs accounting for inversion
** Low frequency is defined here as 0.024 ≤minor allele frequency ≤ 0.05.both night sleep and night sleep CVE on 3L (Figures 4a
and 5a). There were no large LD regions associated with
day average bout length (Figure 4b), but many small re-
gions were identified. For waking activity, we observed LD
between SNPs in a ~2,569 kb region on chromosome 2R
between SNPs in the coding region of CG16868 and the
region forward of RpL23 (Figure 4c). For day sleep CVE, we
observed LD in a region surrounding and including ms(2)
34Fe on chromosome 2L (Figure 5b). It is not possible to
distinguish causal SNPs within chromosomal inversions
and regions of localized LD. Furthermore, it is not possible
to incorporate the effects of the inversions in the GWA
model as the genotype of each SNP is confounded with the
presence or the absence of the inversion. We therefore des-
ignated one SNP as a proxy for all the significant SNPs
found in a given chromosomal inversion or region of LD
for the purpose of tallying the total number of significant
SNPs, which reduced the total number of significant SNPs
by 18-40% (Table 1). Additional files 9 and 10 provide de-
tailed information on each significant SNP in this study, in-
cluding the classification of SNPs within LD blocks and
chromosomal inversions.
Most SNPs associated with sleep trait means and CVE
were at the low range of the allele frequency spectrum,
with minor allele frequencies between 0.024 and 0.05
(Table 1). Low frequency alleles were associated with short
night sleep duration, long day average bout length, and in-
creased waking activity. Interestingly, the lines most sensi-
tive to random environmental perturbations, i.e., the lines
with the highest CVE, had a preponderance of low-
frequency alleles; this was a feature of the CVE for all sleep
traits. As anticipated, low minor allele frequencies were











82.0 95.6 53 456 52
76.0 0.0 0 23 0
33.3 0.0 0 0 0
82.1 0.0 2 103 0
100.0 0.0 6 1 0
100.0 0.1 551 3 2
80.7 10.6 87 970 45























































































Figure 4 Genome wide association results for mean sleep traits. Significant SNPs (FDR≤ 0.01) are plotted. The top panel shows the minor
allele frequency (MAF) for each significant SNP. Effect sizes normalized by the phenotypic standard deviation (a/σP) are plotted in the middle
panel. P-values are plotted as –log10(P-value) in the bottom panel. The lower triangle shows the distribution of linkage disequilibrium among
SNPs as r2. Solid black lines identify the five major chromosome arms. (a) Night sleep. (b) Day average bout length. (c) Waking activity.
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http://www.biomedcentral.com/1471-2164/14/281(Additional file 11), and effect sizes for each SNP were
large (Additional files 9 and 10). The genetic variance (VG)
explained by each SNP in a population of inbred lines is
VG = 4pqa
2, where p and q are the frequencies of the major
and minor alleles, and a is one half of the difference in
mean between lines bearing the major and minor alleles
[27]. Summing the genetic variance over all SNPs overe-
stimates the total genetic variance. This is because SNPs
are not totally independent due to chromosomal inver-
sions and residual LD (Figures 4 and 5; Additional files 9
and 10); the threshold chosen to minimize false negative as-
sociations will include variable numbers of false positive as-
sociations; and the truncated distribution of effect sizes, inaddition to sample size considerations, leads to an overesti-
mation of the amount of variance explained known as the
Beavis effect [28]. We therefore performed iterative GWA
analyses that estimated the additive effects of multiple SNPs
simultaneously. We found that 1–4 SNPs could be used to
explain 19.5-55.5% of the genetic variance in sleep in fe-
males, and 18.0-55.6% of the genetic variance in sleep in
males (Additional file 12). Roughly half (54.4%) of the SNPs
we found using the additive multi-SNP model were also sig-
nificant as a single SNP; the remain- der only appear when
considered as part of the multi- SNP model.
Further experimental work is required in order to de-













































































































Figure 5 Genome wide association results for sleep CVE traits. Significant SNPs (FDR≤ 0.01) are plotted. The top panel shows the minor
allele frequency (MAF) for each significant SNP. Effect sizes normalized by the phenotypic standard deviation (a/σP) are plotted in the middle
panel. P-values are plotted as –log10(P-value) in the bottom panel. The lower triangle shows the distribution of linkage disequilibrium among
SNPs as r2. Solid black lines identify the five major chromosome arms. (a) Night sleep CVE. (b) Day sleep CVE. (c) Day bout number CVE. (d) Waking
activity CVE.
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http://www.biomedcentral.com/1471-2164/14/281inversions or regions of local LD. However, we note that
many of the SNPs are in plausible candidate genes, in-
cluding 19 genes in which mutations were previously as-
sociated with Drosophila sleep (Additional file 13), and
10 genes for which the human ortholog has been associ-
ated with sleep and sleep disorders in humans, nine of
which are not in LD with other genes (CG31646, dnc,
Dscam, eya, l(3)82Fd, nudE, ppan, and trbl) and one
(Lar) that is in LD with other potential candidate genes
(Table 2). Of the 1,300 genes associated with one or more
sleep traits, 213 are associated with potentially functional
missense or nonsense mutations [20]; 757 are expressed
in the adult brain and 764 are expressed in the larval
CNS [29]. The coding sequence of most genes associated
with sleep (419) appeared to be under purifying selection,
consistent with previous observations [7], but some
genes (17) were rapidly evolving [20]. Several (10) genes
were previously identified as quantitative trait transcripts
associated with natural variation in sleep in 40 DGRP
lines [7]; and 320 genes, although previously not impli-
cated in sleep, are associated with SNPs with P-values
exceeding a Bonferroni correction (P < 2 × 10-8) for mul-
tiple tests.
We hypothesized that the list of genes associated with
SNPs affecting one or more sleep traits would be enriched
for causality. If so, groups of genes should be enriched forTable 2 Candidate genes from this study with human homolo
Human sleep trait or disorder Human gene Sleep trait
Daytime sleepiness PDE4D Day average bout le
Night sleep CVE
Waking activity CVE
EYA1 Day average bout le
Day bout number CV
Usual bedtime OPCML Day average bout le
Night sleep CVE
Waking activity CVE
Sleep duration NCOA7 Waking activity
Night sleep CVE
Waking activity CVE
Narcolepsy P2RY11 Day sleep CVE
TRIB2 Day bout number CV
Dscam Day average bout le
Restless Leg Syndrome MEIS1 Waking activity
Waking activity CVE
PTPRD Waking activity CVE
Sleep Apnea ApoE Night sleep
Day average bout le
Night sleep CVEparticular Gene Ontology (GO) terms or pathways [30].
We found 1,126 GO terms that exceeded a P-value of 0.05
(Additional file 14). Genes involved in developmental pro-
cesses of all kinds were a common theme for all sleep traits,
including nervous system development and axonogenesis.
Further, we found significant enrichment for genes associ-
ated with the Epidermal growth factor receptor (Egfr) path-
way (P = 0.015). Egfr signaling has recently been implicated
in D. melanogaster sleep in an independent study [31]. We
used the BIOGRID data base of genes with known physical
and genetic interactions [32] to query our SNP list for
genes that may interact with Egfr. A total of 114 genes
implicated by the sleep GWA analyses formed a candidate
interaction network with genes from the Egfr pathway
(Figure 6, Additional file 15).
Functional tests
We selected mutations and RNAi knockdown constructs in
eleven genes to evaluate effects on the mean and CVE of se-
lected sleep traits, using the criteria that the corresponding
SNPs had high statistical significance in the GWA analyses
(Additional files 9 and 10), the genes were ‘hubs’ in the Egfr
interaction network (Figure 6), and the mutant or RNAi al-
leles were available from Drosophila stock collections with
co-isogenic controls. We tested P-element insertions in
frizzled (fz), thickveins (tkv), Ultrabithorax (Ubx), andgues implicated in normal and disordered sleep
D. melanogaster gene References
ngth dunce (dnc) [43]




peter pan (ppan) [44]
E tribbles (trbl) [45-47]
[48]





Figure 6 Inferred sleep network. Pink denotes genes that are part
of the dorso-ventral axis formation (Egfr) pathway (Egfr, rho, S, drk,
and phl); blue denotes genes tested in this study (brk, fz, Hey, scrib,
tkv, and Ubx); green denotes bun, a gene previously identified as a
candidate gene for sleep in D. melanogaster [39].
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http://www.biomedcentral.com/1471-2164/14/281Vesicular monoamine transporter (Vmat) for their effects
on sleep. We also tested the effect of pan-neuronal knock-
down of gene expression on sleep using RNAi constructs
in candidate genes for sleep. We used an elav-GAL4 driver
to reduce the expression of these genes in all neurons (see
Methods). We tested RNAi constructs in brinker (brk),
CG11163, CG12163, CG14545, Hairy/E(spl)-related with
YRPW motif (Hey), scribbled (scrib), and unc-119. Vmat,
brk, CG14545, scrib, and unc-119 were implicated in night
sleep. Many significant SNPS were present in Vmat introns
and the 30-UTR; these SNPs were significant for males, fe-
males, sexes pooled, and SNP × sex interactions. brk and
CG14545 had at least one SNP in the coding region; these
SNPs were significant for sexes pooled and females separ-
ately in the GWAS. Many SNPs significant for females as
well as both sexes pooled were located in the intergenic re-
gion of unc-119, but this gene is nested within an intron of
a larger gene, CG1677; the SNPs in scrib were also intronic.
Tests of the Vmat mutation for night sleep revealed a sig-
nificant genotype × sex interaction, partially confirming the
GWAS observation. The putative RNA reduction in brk,
CG14545 and unc-119 gene expression resulted in signifi-
cant differences from the control in females and averaged
over both sexes, confirming the GWAS results. However
night sleep in scrib was not significantly different from the
control (Figure 7a and Additional file 16). We tested two
mutations (fz and Vmat) and seven RNAi constructs (brk,
CG11163, CG12163, CG14545, Hey, scrib, and unc-119) for
their impact on night sleep CVE. A single SNP in an intron
of fz was significant for females only in the GWAS.
CG11163, CG12163 and Hey had SNPs significant for both
sexes in the genome-wide association that were located in
the 50-UTR, the 30-UTR, and in an intron, respectively.
Only the CG14545 and Hey RNAi constructs had effects
on night sleep CVE that were consistent with the GWASanalysis (Figure 7b and Additional file 16). We also evalu-
ated the effect of mutations on day average bout length. In
the GWAS, a female-specific SNP in the 30-UTR of Vmat
and intronic SNPs in Ubx were implicated in day average
bout length; however, mutations in these genes failed to
replicate these findings (Figure 7c). We tested mutations in
tkv and Ubx for their impact on day bout number CVE as
SNPs in introns of these genes were significant for both
sexes, but we did not find any change in phenotype due to
these mutations (Figure 7d). Finally, we tested three muta-
tions (fz, tkv, and Ubx) and one RNAi construct (scrib) for
their effect on waking activity CVE. The mutation in fz was
significantly different from the control for sexes combined,
replicating the GWAS finding (Figure 7e and Additional
file 16).
Although we specifically tested the mutations and RNAi
constructs for the effects outlined above, we observed sig-
nificant effects on other sleep phenotypes as well. In fact,
every gene tested exhibited pleiotropy (Figure 7, Additional
files 16 and 17). We observed pleiotropic effects in night
sleep (fz, tkv, Ubx and Hey); night sleep CVE (tkv and unc-
119); day average bout length (fz, CG11163, CG12163 and
unc-119); and day bout number CVE (fz and brk). In gen-
eral, the pleiotropy occurred in sleep phenotypes having
some degree of genetic correlation with the trait of interest
(Additional files 1 and 17). These confirmatory tests dem-
onstrate that candidate genes impacting both mean and
CVE sleep phenotypes can be identified from their respect-
ive SNP associations, and mutations in these genes can also
influence these traits as well as other correlated traits
(Additional files 16 and 17).
Discussion
The DGRP is a new community resource for GWA ana-
lysis of complex traits [20]. The DGRP lines harbor most
common variants and a representative sample of rare vari-
ants that have survived natural selection, and the ~2.5 mil-
lion SNPs interrogated in GWA studies represent novel,
subtle variants that are unlikely to be produced by muta-
genesis screens. We found substantial genetic variation for
sleep traits in the DGRP, as has been observed previously
in natural populations of flies [7,22]. A prominent feature
of the genetic architecture of naturally occurring variation
for all sleep traits is variation in sex dimorphism among
the lines. Using a conservative FDR threshold of 0.01, we
found a total of 2,427 unique SNPs associated with night
sleep duration, day bout number, day and night average
bout length, and waking activity. Some SNPs were in gen-
omic regions containing chromosomal inversions or local
LD; consequently, we could not distinguish among candi-
date SNPs in these regions. Defining a proxy SNP for those
SNPs within inversions or LD groups reduced the putative
number of SNPs to 2,233 SNPs. Consistent with the obser-
















































































































































































































































































































































































































































































































































































































Figure 7 (See legend on next page.)
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Figure 7 Results of mutant and RNAi knockdown tests for night sleep parameters. Results are grouped with their respective isogenic
control, shown in gray. Combined-sex data are shown. Genes that were identified in the GWAS for a given trait are in the darker shade; genes
not significant in the GWAS for a given trait are in the lighter shade. (a) Night sleep. (b) Night sleep CVE. (c) Day average bout length. (d) Day
bout number CVE. (e) Waking activity CVE. ns, not significant; * 0.01 ≤ P < 0.05; ** 0.001≤ P < 0.01; *** 0.0001≤ P < 0.001; **** P <0.0001.
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sex-biased. A few SNPs were sex-antagonistic, i.e., with op-
posite effects in males and females. Interestingly, some
SNPs were located within the canonical sex determination
gene fruitless. However, the mechanism underlying sex-
specific or sex-biased SNP effects on sleep phenotypes is
unknown.
Variation in quantitative traits is traditionally partitioned
into genetic (VG) and environmental (VE) variance, where
the environmental variance reflects variation among indi-
viduals due to non-genetic causes [27]. In experimental
populations reared under constant environmental condi-
tions, VE reflects variation among individuals due to sensi-
tivity, or plasticity, of alleles to intangible environmental
variance. Evidence has been accumulating recently that
there is often genetic variation in environmental sensitivity
[23]; i.e., different genotypes exhibit more or less variation
in the face of minor environmental perturbations [33-35]. If
environmental variation is at least partially under genetic
control, then trait values will be inconsistent for highly sen-
sitive genotypes [36]. It would not be sufficient, therefore,
to know only those variants that are risk alleles for the
mean phenotypes used in diagnosis because one could not
accurately predict which individuals would be afflicted. En-
vironmental sensitivity may explain in part why some risk
alleles are present in unaffected individuals [37]. Currently,
the genetic architecture of genetic variation in environmen-
tal variation is not known. Do the same variants that affect
the trait mean also affect differences in environmental vari-
ation, or is genetic variation in the mean and environmental
variance uncorrelated? The DGRP population of inbred
lines derived from wild-caught flies is an ideal scenario for
estimating the extent to which there is genetic variation in
environmental plasticity and mapping genetic variants asso-
ciated with these traits. We found substantial genetic vari-
ance in environmental variance, measured as the coefficient
of environmental variance, CVE, to correct for any correl-
ation between the mean and variance within a genotype.
We found 5,963 SNPs associated with CVE of sleep traits;
3,077 of which were in intergenic regions and 2,886 in an
annotated gene. Although the trait mean was not corre-
lated with CVE for night average bout length, all other
sleep traits were correlated with their respective CVE to
some degree, and in several cases, the correlation between
trait mean and CVE was strong. For example, nearly all of
the SNPs associated with mean night sleep duration
(95.6%) were also associated with CVE of night sleep. Flieswith short-sleeping genotypes tend to have higher CVE and
are thus more sensitive to changes in the micro-en-
vironment, making short sleep an inherently less stable
phenotype than long sleep. This apparent instability has
also been observed in severe short-sleeping mutants of D.
melanogaster, where genetic modifiers increasing sleep
tend to accumulate [13,38]. For all sleep traits, low-
frequency alleles were associated with genotypes having
higher CVE, i. e., higher sensitivity, and common alleles
were associated with more canalized genotypes. This ob-
servation suggests that if low frequency alleles are deleteri-
ous, they could ‘escape’ natural selection because some
individuals with low frequency alleles will have the same
phenotype as those bearing the common allele.
The majority of loci implicated to affect sleep in our
analysis of natural variants are novel, many are in non-
coding, intergenic regions, and several SNPs could poten-
tially affect more than one gene. In total, we found 1,237
genes associated with one or more mean or CVE sleep
traits, including 19 genes previously associated with sleep
in D. melanogaster, such as Epidermal growth factor recep-
tor [31], bunched [39], Pigment-dispersing factor recep-
tor [40], rhomboid [31], Shaker [13], and Syndecan [41]
(Additional file 13). We searched the NCBI HomoloGene
(Release 65) data base [42] to assess whether candidate
genes from this study had homologues of genes previously
implicated in human sleep studies, and identified 10 genes
with human homologues affecting normal sleep character-
istics as well as the sleep disorders narcolepsy, Restless
Leg Syndrome (RLS), and sleep apnea (Table 2). A single
human study has associated SNPs in the Framingham
Heart Study Offspring Cohort with normal sleep charac-
teristics including daytime sleepiness, usual bedtime, and
sleep duration. Daytime sleepiness, a subjective assess-
ment made by study participants using the Epworth
Sleepiness Scale, was associated with several SNPs, includ-
ing a SNP in an intron of phosphodiesterase 4D (PDE4D)
and one in the intron of eyes absent 1 (EYA1) [43]. In our
study, the fly homologs of these genes, dunce and eyes ab-
sent, were also associated with sleep (Table 2). A non-
synonymous SNP in neuropeptide S receptor 1 (NPSR1)
was associated with usual bedtime, an indicator of diurnal
preference, in the human study [43]. We found SNPs in
the fly homolog of this gene, CG31646. Sleep duration was
associated with nuclear receptor coactivator 7 (NCOA7) in
humans [43], and its fly homolog l(3)82Fd was associated
with night sleep and waking activity in flies.
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sleep disorders. Narcolepsy is a chronic condition charac-
terized by intense sleepiness during the day and disturbed
sleep patterns at night. In some cases, individuals also ex-
perience cataplexy, a sudden loss of muscle control. Narco-
lepsy may be the result of the immune system attacking its
own hypocretin neurons, as several loci associated with
narcolepsy are involved in immune system function, such
as the purinergic receptor P2Y11 (P2RY11) gene [44]. Fur-
ther, antibodies of tribbles homolog 2 (TRIB2) were in-
creased in the blood of narcoleptic patients [45-47],
although their presence may not be causal [48]. Linkage
mapping of a large family identified a region that includes
Down syndrome cell adhesion molecule (Dscam) precursor
in narcolepsy [49]. Fly homologues of these human genes,
peter pan, tribbles, and Dscam, had significant SNPs asso-
ciated with sleep phenotypes (Table 2).
We also found SNPs associated with fly sleep in three
genes that are homologous to candidate genes identified
for Restless Leg Syndrome (RLS), a neurological disorder
distinguished by pronounced discomfort in the lower limbs
that leads to disturbed sleep patterns. Loci implicated in
RLS GWA studies include the developmental gene MEIS
homeobox 1 (MEIS1) [50] and Protein tyrosine phosphatase
receptor type D (PTPRD) [51]; we found significant SNPs
in their fly counterparts - homothorax and Leukocyte-anti-
gen-related-like, respectively, though Lar is located in a
block of local LD (Table 2).
Like narcolepsy, obstructive sleep apnea results in day-
time sleepiness; but it is the result of closure of the upper
airway during sleep, blocking oxygen intake for short pe-
riods and thereby disrupting sleep. apolipoprotein E
(APOE) is associated with sleep apnea in a context-
dependent manner, with the association stronger in youn-
ger individuals, and those with cardiovascular disease or
hypertension [52]. The fly homolog of APOE, nudE, was
implicated in our study.
While the DGRP fly lines do not represent models of
these human sleep disorders, it is remarkable that many ho-
mologues of candidate genes for human sleep as well as
sleep disorders emerge in this association study of endogen-
ous sleep phenotypes in flies. If one assumes that human
sleep disorders are the result of mis-regulation of normal
sleep genes, this observation suggests that the role of these
genes in sleep may be conserved across species [53].
We identified a network of 114 genes associated with
sleep phenotypes in the DGRP that are known to inter-
act either genetically or physically with Egfr (Figure 6,
Additional file 15). Prior analyses have demonstrated ef-
fects of a few of these genes on adult sleep in Drosophila
[31,39]; therefore the network generates testable hypoth-
eses. We tested for altered sleep phenotypes in six novel
candidate genes from the network: brk, fz, Hey, scrib, tkv,
and Ubx, all of which have been previously studied fortheir role in development. We demonstrated that a P-
element insertion in fz and pan-neuronal reduction in
gene expression in brk and Hey recapitulated the GWAS
results. fz is involved in synapse development and in
planar cell polarity [54]. brk is a DNA-binding protein
that can act to repress genes that are the targets of
Decapentaplegic signaling [55]. Hey is a transcription fac-
tor that is a target of Notch signaling in neuroblasts, and
exhibits Notch-independent expression in precursor neu-
rons of the mushroom bodies as well [56]. That these
genes, along with many of the genes identified in this
GWAS, have a role in neural development and cellular
morphogenesis begs the question of whether sleep behav-
ior is partly the result of neural architecture, or whether
the genes have an additional role in the adult fly. The
GWAS results suggest that biological processes in
addition to neural development play a role in sleep, how-
ever. We tested genes affecting other biological processes,
as well as three genes with unknown function (CG14545,
CG11163, and CG12163). Note that unc-119, a homolog
of the C. elegans unc-119 gene [57], and brinker are within
the intron of a larger gene, CG1677. It is not clear at this
point which of these genes may be relevant to sleep. We
also tested a mutation in Vmat, which transports dopa-
mine, serotonin, and octopamine [58], monoamines
known to affect sleep in Drosophila [38,59,60]. We saw
significant differences in the expected sleep phenotypes
for RNAi constructs of CG14545 and unc-119, and a P-
element insertion in Vmat.
All of these mutations and RNAi constructs exhibited
significant effects in sleep phenotypes other than those
tested, revealing pervasive pleiotropy. The BG01047 P-
element insertion in fz, for example, was the most highly
pleiotropic mutant we observed. We chose it to test it
based on the night sleep CVE and waking activity CVE
GWAS results, yet significant pleiotropic effects were ob-
served in day and night bout number, day and night sleep,
day and night average bout length, day and night bout
number CVE, and day and night average bout length CVE
(Additional file 17). We observed 71 instances of pleiotropy
in the tested candidate genes. Most of the unexpected
pleiotropic effects (57 out of 71) occurred between sleep
traits with statistically significant (although not necessa-
rily high) genetic correlations in the DGRP population
(Additional file 1). Pleiotropic effects of a mutation or
RNAi allele that were not observed in the DGRP popula-
tion can occur because genetic correlations in a natural
population are indicative of pleiotropic effects of naturally
occurring alleles that are in the same direction. Further, the
effect sizes for most SNPs associated with sleep traits are
in the range of 0.3 to 0.7 standard deviations, which is rela-
tively small compared to the effects that might be expected
with a null mutation. Thus, only when a mutation or RNAi
construct is sufficiently severe do we observe the effect on
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account for the unexpected pleiotropic effects of tested
candidate genes on day bout number and waking activity,
which were not correlated with the traits being tested
(Additional file 17). We observed substantial pleiotropy at
the level of individual SNPs as well as at the level of genes
(Additional files 9 and 10). Given the generally rapid decay
of LD in this population (over 10–30 bp) [20], non-
overlapping SNPs that are associated with different traits
may evolve independently, as has been observed previously
[61]. In total, we observed 103 SNPs and 254 genes associ-
ated with two or more sleep traits.
The above discussion does not include SNPs associated
with sleep traits in chromosomal inversions and regions of
local LD. Three chromosomal inversions were significantly
associated with sleep: ln_2L_t, which was significantly asso-
ciated with day sleep, day sleep CVE, day bout number
CVE, and night bout number CVE; ln_2R_NS, which was
significantly associated with day average bout length mean
and CVE and day bout number; and ln_3R_Mo, which was
significantly associated with day average bout length mean
and CVE and waking activity CVE. Furthermore, we found
193 and 418 regions of local LD for mean and CVE sleep
traits, respectively (Additional files 9 and 10). The vast ma-
jority of these LD regions (96.4%) contain 10 or fewer
SNPs. We cannot distinguish which of the SNPs in these
regions are potentially causal from the GWA analyses. It
may be possible to determine the SNPs that are causal in
LD regions by crossing lines of the DGRP together and
performing a second association study once recombination
has occurred over several generations. The chromosomal
inversions present a more challenging problem, however,
as recombination is effectively suppressed in these regions.
Here we associated fourteen sleep phenotypes with
2,490,195 SNPs in the DGRP. Although this analysis was
blind to SNPs with minor allele frequencies less than
0.024 and non-SNP variants (insertions, deletions, trans-
locations, transposable elements, copy number variants),
we nevertheless found that a few SNPs in purely additive
multi-SNP models could explain a large fraction of the
genetic variance. This is in sharp contrast to the situation
in human GWA studies [62,63], in which individuals SNPs
explain only a small proportion of the total phenotypic
variance. This is likely in part because sleep measures in
this study were replicated for each genotype, which
increases the statistical confidence in these measures. In
addition, all flies were reared under controlled environ-
mental conditions from staging the parental cultures until
sleep and activity monitoring were completed at the adult
stage. One potential reason for the ‘missing’ heritability in
human association studies [62,63] is that the true causal
variants are not common, and thus poorly tagged by com-
mon SNPs used in the genotyping platforms [64]. Our as-
sociation study included all variants with frequenciesgreater than 2.4%, and found that the lower frequency vari-
ants had the largest effects, supporting the rare variants
hypothesis.Conclusions
While much work remains to be done in order to under-
stand the purpose of sleep, this study gives us some
insight as to how genetic variation for sleep might be
maintained. A number of genes for sleep have been previ-
ously identified by random mutagenesis screens in Dros-
ophila. These studies have revealed genes important to
sleep. However, these genes may be invariant in natural
populations if, for instance, they are under strong purify-
ing selection; if this is the case, they will not contribute to
the maintenance of genetic variation in sleep. This study
found that 19 of the genes already known to affect sleep
in Drosophila affect genetic variation in a natural popula-
tion as well (Additional file 13). The Gene Ontology ana-
lysis suggests that genes impacting sleep fall into very
broad categories such as nervous system development
and signal transduction. Further, genes in the Egfr signal-
ing pathway were over-represented in this study,
suggesting that polymorphisms in their component genes
impact genetic variation in sleep. The Egfr pathway is a
primary signaling cascade with multiple effects in the
regulation of cell fate determination and morphogenesis
and affects many downstream biological processes [65],
implying that sleep is connected to many biological pro-
cesses. The network derived from the SNP associations
presents a working hypothesis for how polymorphic vari-
ants for sleep might interact. Note that many of the SNPs
we identified herein are found in novel, computationally
predicted genes having functions hypothesized on the
basis of homology to genes in other species. A GO ana-
lysis using only the 579 computationally predicted genes
from this study reveals additional pathways important for
sleep. For example, most of the predicted genes are inte-
gral to the membrane, and many are predicted to catalyze
the transport of substances from one side of the mem-
brane to the other or to have a function in proteolysis.
A major challenge in human GWA studies is the inabil-
ity to directly demonstrate that a candidate SNP causes
the phenotypic variation. Drosophila, however, can be ma-
nipulated with transgenic approaches, crosses between dif-
ferent genotypes, and artificial selection procedures. This
ability will enable us to determine whether the SNPs we
identified herein are causal, whether the same SNPs have
a role in sleep in different populations of Drosophila,
whether epistatic interactions occur between SNPs, and
the nature of the selective forces acting on sleep. Finally,
this work forms the basis of a systems genetics analysis
that will link polymorphic, molecular, and phenotypic vari-
ation for sleep in multiple environments.
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Quantitative sleep phenotypes
We used the Drosophila Genetic Reference Panel (DGRP)
[20] to assay sleep phenotypes. The DGRP was created by
20 generations of full sib mating of progeny of wild-caught,
gravid females from Raleigh, North Carolina. We randomly
divided the DGRP lines into four equal blocks. Flies were
maintained under standard culture (cornmeal-molasses-
agar medium, 25°C, 60-75% relative humidity) and lighting
conditions (12-hour light: dark cycle). Sleep measurements
were replicated four times for each block of lines. Eight
flies of each sex were measured in each replicate, resulting
in sleep measurements for 32 flies per sex per line. Eight
male and eight female w1118; Canton-S B flies were mea-
sured in each replicate as a control. Virgin males and fe-
males were collected from each line and retained at 30 flies
per same-sex vial to mitigate the effects of both social ex-
posure [66] and mating [67] on sleep. We recorded seven
continuous days of sleep and activity using the Drosophila
Activity Monitoring System (Trikinetics, Waltham, MA),
which measures the number of times a given fly crosses an
infrared beam. Each fly was visually inspected at the end of
the recording period; data from flies that did not live
through the recording period were not used in the sleep
calculations. A C# program (R. Sean Barnes, personal com-
munication) was used to calculate sleep duration, sleep
bout number, average sleep bout length, and waking activ-
ity from the raw activity data. Sleep duration was calculated
as any period of inactivity lasting five minutes or longer, as
previously defined [11,12,22]. Waking activity was calcu-
lated as the number of times the fly crossed the infrared
beam divided by the total time spent awake. Different
genes influence sleep patterns during the day and night [7];
we therefore calculated sleep parameters separately for day
and night. To assess the degree of sensitivity of sleep to the
environment, we calculated the environmental coefficient
of variation CVE of each sleep parameter per line/sex/repli-
cate as (σE/μ) × 100 [33], where σE is the within-replicate
environmental standard deviation and μ is the sleep trait
averaged over each line, sex, and replicate.
Wolbachia pipientis effects
The Wolbachia infection status for each DGRP line has
been determined [20]. We assessed the degree to which
sleep phenotypes were influenced by Wolbachia infection
using the mixed-model ANOVA Y = μ + I + S + I × S + L
(I) + R(I × S × L) + ε, where I designates infection status
(fixed), S is sex (fixed), L is the DGRP line (random), R is
the replicate effect (random), and ε is the error variance.
We also used reduced models to examine the effect of in-
fection status on sleep for each sex separately [20].
Wolbachia infection status significantly affected only one
trait, day average bout length, and the effect was only
present in males. Thus, we corrected male day averagebout length line means to account for the influence of
infection.
Quantitative genetic analyses
We partitioned the variance in each sleep parameter and
its respective environmental coefficient of variation CVE
using the ANOVA model: Y = μ +B + S + L(B) + S × L(B) +
R(B) + S × R(B) + R × L(B) + S × R × L(B) + ε, where L (line),
B (block) and R (replicate) are random effects, S (sex) is a
fixed effect, and ε is the error variance. We used reduced
models to partition the variance for each sex separately.
Significant block effects (P < 0.05) were present for some
sleep traits (Additional file 1). Significant block effects may
be due to differences in the environment, or they may sim-
ply be the result of random sampling. To distinguish be-
tween these two possibilities, we analyzed sleep in the
w1118; Canton-S B control line using the reduced model
Y = μ + B + S + B × S + R(B) + S × R(B) + ε. None of the
block terms were significant, suggesting that the significant
differences seen between blocks in the raw sleep data are
due to differences in the lines sampled, not environmental
differences between blocks. We therefore used the raw
sleep data in subsequent analyses.
We estimated variance components using the restricted
maximum likelihood (REML) method. We calculated









for sexes combined, where σ2L is the variance component
among lines, σ2SL is the line-by-sex variance component,
and σ2E is the sum of all other sources of variation. We
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the variance component among lines for sexes combined,
σ2LM is the variance component among lines for males,
and σ2LF is the variance component among lines for fe-
males. We calculated the genetic correlation rG between
each sleep trait rG = cov12/√(σL1
2 × σL2
2) [27], where cov12 is
the covariance between traits 1 and 2, and σL1
2 and σL2
2 are
the among-line variances for traits 1 and 2, respectively.
Genotype-phenotype associations
We associated the line mean of each sleep parameter with
all segregating sites in the DGRP present in four or more
DGRP lines, and having sequence coverage levels greater
than two and less than thirty [20]. We used the ANOVA
model Y = μ + SNP + S + SNP × S + L(SNP) + ε to evaluate
each segregating site [20]. SNP is the genotype effect, while
L and S are as defined above. Genotype-phenotype associa-
tions were also performed for males and females separately
using the reduced model Y = μ + SNP + ε. We defined our
threshold P-values for each sleep trait separately by calcu-
lating the false discovery rate (FDR) using the standard
Benjamini-Hochberg procedure [68]. Significant SNPs
were designated as those with FDR ≤ 0.01. We calculated
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between marker classes divided by the overall phenotypic
standard deviation [27] and the linkage disequilibrium
among significant markers using r2 [69]. It is not likely that
all 2,490,195 SNPs in the DGRP act independently of one
another. The genetic variance explained by each SNP can
be overestimated if population structure is present in
the DGRP, if the SNPs are in linkage disequilibrium, or if
the SNPs are correlated with one another by chance due to
the small size of the DGRP. We saw evidence of a devi-
ation from the expected P-value distribution in the original
analysis. We therefore checked for population structure by
incorporating the DGRP relationship matrix into the
genome-wide association model using Fast-LMM [70,71].
Incorporating the relationship matrix did not explain the
deviation of the observed P-value distribution from the
expected distribution, suggesting that there was no popula-
tion structure due to population admixture in the DGRP.
We associated the presence or absence of chromosomal
inversions present in the DGRP (M. A. Carbone, A.
Yamamoto, Y. Inoue, and T. F. C. Mackay, personal com-
munication) with sleep phenotypes using the model Y = μ +
Inv + S + Inv × S + ε, where Inv denotes the presence or ab-
sence of the inversion, and S and ε are defined above. As
these chromosomal inversions and LD blocks are the likely
source of the deviations of the observed distribution of
P-values from expectation under the null hypothesis of no
association, we counted significant SNPs within these re-
gions as a single SNP. We also performed iterative GWA
analyses that incorporated the additive effects of multiple
SNPs. We used the model,Y = μ + SNP1 + SNP2 + SNP3 +…
SNPN + ε, where SNP1, SNP2, SNP3, …, SNPN are the most
significant SNPs fitted in succession into the model. In this
model, SNP1 is the most highly significant SNP in the ori-
ginal genome-wide analysis. SNP2 is the most highly signifi-
cant SNP in the genome-wide analysis after SNP1 is fitted
into the model, SNP3 is the most highly significant SNP in
the genome-wide analysis after SNP1 and SNP2 are fitted
into the model, and so on. We continued to fit SNPs to the
model until the r2 parameter was maximal.
Verification of genotype-phenotype associations
We used the SNP locations to determine which SNPs were
located within annotated D. melanogaster genes for all
mean and CVE sleep traits (Additional files 9 and 10). We
searched the DAVID bioinformatics database [30] for path-
ways with significant enrichment for these genes. The Epi-
dermal growth factor receptor (Egfr) pathway was highly
significant. We then used BIOGRID [32], a data base com-
piled from the literature of known protein-protein and gen-
etic interactions, to search our gene list for interactions
with the genes in the Egfr pathway. We identified candidate
genes previously reported to interact with this pathway, and
constructed a network around the Egfr pathway basedon these interactions. We chose mutations in highly-
connected genes from this pathway for further testing. We
used homozygous P-element insertion lines from the
Exelixis and MB stock collections, which were produced in
an isogenic background and therefore have an isogenic con-
trol [72,73]. We tested Minos mutations for Vmat (Mi{ET1}
VmatMB04557) and tkv (Mi{ET1}tkvMB02285. We tested the
Exelixis mutation Pbac{WH}Ubxf07161 in Ultrabithorax. We
also tested BG01047, a line with a P[GT1] P-element inser-
tion in the gene fz [74]. This insertion also has an isogenic
background, w1118; Canton-S. In addition, we used RNA
interference to knock down the expression of selected
genes in all fly neurons. We tested the effects of RNAi
knockdown in the following genes and compared them to
the isogenic control line y,w1118;P{attP, y+, w3}: brinker101887,
CG11163107931, CG12163107589, CG14545103660, Hey103570,
scribbled100363, and unc-119107987 (Vienna Drosophila RNAi
Center) [75]. We used the P{[w+Mc] =GAL4-elav.L}2/CyO
line (8765) from the Bloomington Stock Center to drive ex-
pression pan-neuronally.
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